# Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules

> **NCT06823895** · PHASE1 · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Maixuekang capsule

## Key facts

- **NCT ID:** NCT06823895
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06823895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06823895, "Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06823895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*